Comparative Study of Tirzepatide Versus Dulaglutide (SURPASS CVOT) or Semaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes (opens ClinicalTrials.gov)
- Sponsor
- Brigham and Women's Hospital
- Enrolment
- 70,000
- Started
- 2024-11-01
- Last update
- 2026-09-18
Conditions: Type 2 Diabetes
Interventions: Tirzepatide, Dulaglutide, Semaglutide